Camille Delebecque

Camille Delebecque is a prominent figure in the biotechnology sector, currently serving as the Head of Biotechnology at Verb Biotics LLC. With a strong academic background, Delebecque has earned degrees from prestigious institutions, including a PhD in Synthetic Biology and Biotechnology from Harvard University and Paris Descartes University, where they graduated with highest honors.

Education and Academic Achievements

• PhD in Synthetic Biology & Biotechnology: Jointly supervised by renowned professors at Harvard Medical School and Paris Descartes University. Their thesis work has been published in leading scientific journals such as Science and Nature Protocols.
• Masters in Agronomical Engineering: From AgroParisTech, focusing on life sciences, food sciences, and environmental management. Delebecque received the Best Master Thesis Award from Veolia National Contest.
• Additional Training: Completed a program at Harvard Business School on inventing breakthroughs and commercializing science.

Professional Experience

Delebecque has extensive experience in business development, research and development, and innovation strategy within the biotech field. They have developed platform technologies for genetic engineering with applications across various sectors including bioenergy, agriculture, and pharmaceuticals.

Contributions to the Field

Delebecque is recognized for their contributions to synthetic biology and has received multiple awards for their research, including:

• Best Life Science PhD award from the Chancellerie des Universités de Paris.
• Grand Prize Winner at the 5th International Meeting in Synthetic Biology.

In addition to their role at Verb Biotics LLC, Delebecque is actively involved in consulting and entrepreneurship focused on harnessing microbial technology for health, food, and agriculture applications.